2PointZero Group announced it has invested in the Series G preferred equity financing round of WHOOP, strengthening its exposure to the fast-growing consumer health technology sector. Moreover, the round was led by Collaborative Fund, with participation from other investors alongside 2PointZero.
Investment strengthens wellness technology exposure
Founded in 2012 and headquartered in Boston, WHOOP operates a subscription-based platform offering continuous health monitoring, personalised coaching, and wellness insights. Additionally, the company serves members across more than 200 countries and territories, supporting both consumers and enterprise wellness programmes.
2PointZero said the investment expands its presence in consumer-focused industries. Furthermore, it adds a scalable wellness technology platform that complements its existing Wellness vertical. As a result, the group aims to align its portfolio with businesses that have recurring revenue models and multiple growth drivers.
Executives highlight scalability and market growth
Samia Bouazza, CEO of 2PointZero Group, said, “At 2PointZero, we deploy capital where growth, strong fundamentals, and scalability align. We believe WHOOP has built a defensible moat at the intersection of technology, health, and data and is a category-defining platform with strong unit economics, a deeply engaged community, and a clear path toward scaled profitability.
More broadly, this investment reinforces our conviction in consumer health technology as a long-term growth vertical. The global consumer wearables market is projected to grow at an extraordinary annual pace, reaching close to $300 billion by 2032. This investment reflects our strategy of backing strong founders and management teams to accelerate growth and compound shareholder value over time.”
Will Ahmed, Founder and CEO of WHOOP, commented, “We are proud to partner with 2PointZero Group as WHOOP enters its next phase of global growth. We’ve been building our presence in the UAE since 2017, when we first partnered with Expo 2020 Dubai. Today, the UAE has become one of our strongest international markets. This investment will help accelerate our growth in the UAE and globally as we continue to redefine how people understand and improve their health.”
UAE expansion and product innovation support outlook
WHOOP recently launched its 5.0 and MG wearable devices in May 2025. Additionally, the products earned recognition on TIME Magazine’s “Best Inventions of 2025” list.
The company also partnered with Unilabs to expand its Advanced Labs programme in the UAE. Furthermore, the initiative provides members access to a 65-biomarker blood testing panel nationwide. Therefore, the expansion supports WHOOP’s broader strategy to deepen its presence in the UAE while accelerating global growth.
